UNLIMITED TURBO LONG - UCB Share Price

4H4MB

NLBNPNL2K7I3

Real-time Euronext Paris 04:59:28 11/06/2024 pm IST
16.06 ^EUR	+0.88%

Current month	+2.54%
1 month	+9.57%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

European shares steady after French political tremors, eyes on Fed	02:30pm	RE
UCB : Acquisition of own shares	31/05	PU
UCB : Commitment to Innovation in Drug Development	29/05	PU
UCB : announces publication in The Lancet of phase 3 bimekizumab▼ trials in moderate to severe hidradenitis suppurativa	23/05	PU

More news

Quotes 5-day view

Date	Price	Change
11/24/11	16.06	+0.88%
10/24/10	15.92	0.00%
07/24/07	15.92	+0.47%
06/24/06	15.84	+0.13%
05/24/05	15.82	+2.33%

Real-time Euronext Paris

Last update June 11, 2024 at 04:59 pm IST

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	CALL
Underlying	UCB
Issuer	BNP Paribas
	4H4MB
ISIN	NLBNPNL2K7I3
Date issued	09/11/2023
Strike	51.91 €
Maturity	Unlimited
Parity	5 : 1
Emission price	3.37 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	17.18 €
Lowest since issue	3.15 €
Spread	0.02 €
Spread %	0.12%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

130 EUR

Average target price

133.4 EUR

Spread / Average Target

+2.57%

Consensus